International Journal of General Medicine (Feb 2024)
Predictive Value of MHR and NLR for Ulcerative Colitis Disease Activity
Abstract
Tian Liu, Zhenkun Qin, Zhiyue Yang, Xiaoling Feng Division of General Practice, The Fifth Affiliated Hospital of Xinjiang Medical University, Urumqi, People’s Republic of ChinaCorrespondence: Xiaoling Feng, Division of General Practice, The Fifth Affiliated Hospital of Xinjiang Medical University, No. 118, Henan West Road, Urumqi, Xinjiang Uygur Autonomous Region, 830011, People’s Republic of China, Email [email protected]: Numerous non-invasive serologic tests are available to diagnose and monitor ulcerative colitis (UC), but their accuracy levels are limited. Thus, there is a pressing need for a serologic biomarker with higher precision for clinical practice. This study aims to evaluate the predictive capacity of monocyte/HDL ratio (MHR) and neutrophil/lymphocyte ratio (NLR) for UC disease activity.Patients and Methods: We conducted a retrospective analysis of 81 UC patients and 77 age- and sex-matched healthy controls. UC patients were categorized into active and inactive groups based on the Mayo score. The Mayo endoscopic subscore classified them into mild-to-moderate and severe UC groups.Results: The optimal cut-off values for diagnosing UC were 0.34 for MHR (85.7% sensitivity, 76.0% specificity, 88.9% positive predictive value, 70.4% negative predictive value) and 2.49 for NLR (66.1% sensitivity, 88.0% specificity, 92.5% positive predictive value, 53.7% negative predictive value). The optimal MHR and NLR cut-off values to differentiate between mild-to-moderate UC and severe UC were 0.38 (92.9% sensitivity, 56.6% specificity, 53.1% positive predictive value, 93.7% negative predictive value) and 3.46 (71.4% sensitivity, 88.7% specificity, 76.9% positive predictive value, 85.5% negative predictive value), respectively.Conclusion: NLR and MHR are simple yet effective biological predictors of disease activity in UC patients.Keywords: ulcerative colitis, monocyte/HDL ratio, neutrophil/lymphocyte ratio, disease activity